Ivanov Aa
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Urology 6
- Periodontal Regeneration and Treatments 6
-
- Electrospun Nanofibers in Biomedical Applications 5
- Co-authors
- D. A. Kharkevich (3 shared papers)Jörg Kreuter (1 shared paper)Renad Nikolaevich Alyautdin (2 shared papers)Helena Engman (1 shared paper)Ryo Atsumi (1 shared paper)Pieter Jaap Gaillard (1 shared paper)Albertus Gerrit de Boer (1 shared paper)Douwe D. Breimer (1 shared paper)
In The Last Decade
Ivanov Aa
52 papers receiving 982 citations
Peers
Comparison fields: 5 of 105
- Pharmaceutical Science 181
- Biomaterials 341
- Neurology 199
- Oncology 187
- Developmental Neuroscience 19
Countries citing papers authored by Ivanov Aa
This map shows the geographic impact of Ivanov Aa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivanov Aa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivanov Aa more than expected).
Fields of papers citing papers by Ivanov Aa
This network shows the impact of papers produced by Ivanov Aa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivanov Aa. The network helps show where Ivanov Aa may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivanov Aa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 476 | |
| 2 | 2001 | 288 | |
| 3 | 2023 | 59 | |
| 4 | 2022 | 18 | |
| 5 | 2023 | 17 | |
| 6 | 2021 | 15 | |
| 7 | 1996 | 13 | |
| 8 | 2008 | 13 | |
| 9 | [C-reactive protein in the blood serum as an indicator of the severity of a radiation lesion]. | 1978 | 13 |
| 10 | 2021 | 10 | |
| 11 | 2016 | 9 | |
| 12 | [Transport of the hexapeptide dalargin across the hemato-encephalic barrier into the brain using polymer nanoparticles]. | 1996 | 9 |
| 13 | 2025 | 9 | |
| 14 | 2024 | 8 | |
| 15 | 2023 | 7 | |
| 16 | [Regulation of erythrocyte membrane resistance to extreme effects of tris-(2-hydroxyethyl)ammonium salt of 4-fluorophenylsulfonylacetic acid]. | 1990 | 5 |
| 17 | 2025 | 5 | |
| 18 | 2015 | 4 | |
| 19 | 2020 | 4 | |
| 20 | [The course and prognosis of mesangioproliferative glomerulonephritis]. | 2002 | 3 |
About Ivanov Aa
Ivanov Aa is a scholar working on Urology, Biomaterials, Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 60 papers that have together received 1.0k indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (6 papers), Effects of Radiation Exposure (6 papers), Periodontal Regeneration and Treatments (6 papers), Electrospun Nanofibers in Biomedical Applications (5 papers), Cancer Cells and Metastasis (4 papers), Renal Diseases and Glomerulopathies (4 papers), Spaceflight effects on biology (4 papers) and Mesenchymal stem cell research (4 papers). The work is most often cited by research in Pharmaceutical Science (181 citations), Biomaterials (341 citations), Neurology (199 citations), Oncology (187 citations) and Developmental Neuroscience (19 citations). Ivanov Aa has collaborated with scholars based in Russia, Germany and Mongolia. Frequent co-authors include D. A. Kharkevich, Jörg Kreuter, Renad Nikolaevich Alyautdin, Helena Engman, Ryo Atsumi, Pieter Jaap Gaillard, Albertus Gerrit de Boer, Douwe D. Breimer, Natalia Y. Shilyagina and Roman A. Verkhovskii. Their work appears in journals such as Herald of the Russian Academy of Sciences, European Journal of Pharmaceutical Sciences, The Nephron journals/Nephron journals, Frontiers in Cell and Developmental Biology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.